Iván Sánchez Fernández Selected Research

Iván Sánchez Fernández Research Topics

Disease

13	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 05/2012
9	Seizures (Absence Seizure) 05/2019 - 01/2014
7	Epilepsy (Aura) 05/2019 - 01/2014
3	Drug Resistant Epilepsy 08/2014 - 05/2014
2	Infantile Spasms (West Syndrome) 01/2021 - 12/2017
2	Spasm (Spasms) 01/2021 - 12/2017
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 11/2017 - 06/2017
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Hypotension (Low Blood Pressure) 01/2018
1	Hypothermia 11/2017
1	Heart Arrest (Cardiac Arrest) 06/2017
1	Critical Illness (Critically Ill) 06/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Gliosis 01/2017
1	Necrosis 01/2017
1	Neoplasms (Cancer) 01/2017
1	Leukemic Infiltration 01/2017
1	Brain Diseases (Brain Disorder) 11/2015
1	Sudden Unexpected Death in Epilepsy 08/2014
1	Epileptic Syndromes 07/2014
1	Nervous System Diseases (Neurological Disorders) 05/2014
1	Paralysis (Palsy) 12/2010
1	Infarction (Infarctions) 12/2010

Drug/Important Bio-Agent (IBA)

8	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 07/2014
2	SteroidsIBA 01/2021 - 11/2015
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 12/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 12/2017
2	Topiramate (Topamax)FDA LinkGeneric 05/2019 - 01/2017
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2019 - 05/2014
2	BenzodiazepinesIBA 01/2018 - 01/2017
2	Midazolam (Versed)FDA LinkGeneric 01/2017 - 10/2016
2	Diazepam (Valium)FDA LinkGeneric 01/2017 - 05/2012
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	perampanelIBA 05/2019
1	brivaracetamIBA 05/2019
1	Ketamine FDA LinkGeneric 05/2019
1	Vigabatrin FDA Link 12/2017
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2017
1	Lorazepam (Ativan)FDA LinkGeneric 01/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 01/2017
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017
1	Pentobarbital (Nembutal)FDA Link 10/2016
1	Anesthetics (Anesthetic Agents)IBA 10/2016
1	Silicone Elastomers (SE 30)IBA 10/2014
1	rufinamide FDA Link 08/2014
1	Clobazam (HR 376)IBA 07/2014
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 05/2014
1	Glutamic Acid (Glutamate)FDA Link 05/2014
1	gamma-Aminobutyric Acid (GABA)IBA 05/2014
1	N-Methylaspartate (NMDA)IBA 05/2014
1	GABA Receptors (GABA Receptor)IBA 05/2014
1	AMPA Receptors (AMPA Receptor)IBA 05/2014
1	Messenger RNA (mRNA)IBA 05/2014
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2014
1	Mydriatics (Cycloplegics)IBA 12/2010

Therapy/Procedure

7	Therapeutics 05/2019 - 08/2014
3	Time-to-Treatment 01/2021 - 01/2018
1	Aftercare (After-Treatment) 01/2021
1	Patient Readmission 01/2020
1	Emergency Treatment 01/2018
1	Treatment Delay 01/2018
1	Induced Hypothermia 11/2017
1	Extracorporeal Membrane Oxygenation 06/2017
1	Artificial Respiration (Mechanical Ventilation) 06/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Radiotherapy 01/2017